加州大学伯克利分校环境科学政策与管理系导师教师师资介绍简介-Mark Tanouye

本站小编 Free考研考试/2022-09-11

Title
Professor of Environmental Science, Policy and Management (Division of Insect Biology)

Department
Dept of Environmental Science, Policy & Management
Dept of Molecular & Cell Biology


Faculty URL
http://mcb.berkeley.edu/index.php?option=com_mcbfaculty&name=tanouyem

Research Group
http://cnr.berkeley.edu/tanouyelab/index.html

Email
tanouye@berkeley.edu

Phone
(510) 642-8786

Fax
510) 642-7428


Search UC Berkeley Directory





Research Expertise and Interest
genetics, neuroanatomy, electrophysiology, mechanisms of nervous system structure and function, drosophila mutants

Research Description
We study Drosophila mutants that have behavioral abnormalities. By determining the genetic and molecular bases of these abnormalities, we are able to unravel new and basic features of nervous system structure and function.
Current Projects
Our approach is to use a combination of methodologies including classical and molecular genetics, behavior, electrophysiology, and neuroanatomy. We are especially interested in developing a Drosophila model system for examining human neuropathologies. Recently, we have been examining seizures, a serious problem in many neuropathologies. They are a major symptom associated with fever, mechanical trauma, electroconvulsive shock, drugs, alcohol, tumors and epilepsy. The long-term objectives of our research are to examine basic nervous system features underlying seizure-sensitivity and to discover novel treatments.
To approach this problem, we have a) invented methods for quantifying seizure-susceptibility in normal and mutant Drosophila; b) identified seizure-sensitive mutants that are especially prone to seizures compared with normal flies; c) identified seizure-resistant mutants that are especially insensitive to seizure-induction; and d) identified seizure-suppressor mutations and seizure-enhancer mutations that allow further genetic manipulation of seizure phenotypes and form the basis for developing promising anticonvulsant therapies. The genetic and molecular biology capabilities in Drosophila that have resolved fundamentally important issues in biology also provide an attractive system for developing new therapies to treat human pathobiology.